These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30120968)

  • 1. MMP14 predicts a poor prognosis in patients with colorectal cancer.
    Cui G; Cai F; Ding Z; Gao L
    Hum Pathol; 2019 Jan; 83():36-42. PubMed ID: 30120968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
    Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
    BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation.
    Wang X; Meng Q; Wang Y; Gao Y
    Medicine (Baltimore); 2021 Aug; 100(32):e26545. PubMed ID: 34397871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
    Du L; Li J; Lei L; He H; Chen E; Dong J; Yang J
    Biomed Res Int; 2018; 2018():6387810. PubMed ID: 29955607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinoma.
    Jin Y; Liang ZY; Zhou WX; Zhou L
    Pathology; 2020 Apr; 52(3):359-365. PubMed ID: 32122646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis.
    Wu G; Chen Z; Li J; Ye F; Chen G; Fan Q; Dong H; Yuan S; Zhu X
    J Cancer; 2018; 9(13):2374-2379. PubMed ID: 30026833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
    Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
    Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer.
    Wang X; Jiang Z; Zhang Y; Wang X; Liu L; Fan Z
    Oncotarget; 2017 Mar; 8(13):21984-21993. PubMed ID: 28423541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
    Ma J; Chang W; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
    Kasurinen A; Gramolelli S; Hagström J; Laitinen A; Kokkola A; Miki Y; Lehti K; Yashiro M; Ojala PM; Böckelman C; Haglund C
    Cancer Med; 2019 Nov; 8(16):6995-7005. PubMed ID: 31560170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
    Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
    Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
    Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
    Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
    Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
    Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of matrix metalloproteinases 16 is associated with the aggressive malignant behavior and poor survival outcome in colorectal carcinoma.
    Wu S; Ma C; Shan S; Zhou L; Li W
    Sci Rep; 2017 Apr; 7():46531. PubMed ID: 28422174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
    Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.